|1.||Bono, Françoise: 2 articles (08/2004 - 09/2003)|
|2.||Herbert, Jean-Marc: 2 articles (08/2004 - 09/2003)|
|3.||Leducq, Nathalie: 2 articles (08/2004 - 09/2003)|
|4.||Casellas, Pierre: 2 articles (09/2003 - 09/2002)|
|5.||Bourrie, Bernard: 2 articles (09/2003 - 09/2002)|
|6.||Bribes, Estelle: 2 articles (09/2003 - 09/2002)|
|7.||Manning, H Charles: 1 article (09/2014)|
|8.||Tang, Dewei: 1 article (09/2014)|
|9.||Buck, Jason R: 1 article (09/2014)|
|10.||Nickels, Michael L: 1 article (09/2014)|
09/27/2002 - "In this study, the effects of different peripheral benzodiazapine receptor ligands: PK 11195 [1-(2-chloro-phenyl)-N-methyl-N-(1-methylpropyl)-1-isoquinoline carboxamide], Ro5-4864 [7-chloro-5-(4-chlorophenyl)-1,3-dihydro-1-methyl-2H-1,4-benzodiazepin-2-one] and the newly described SSR 180575 (7-chloro-N,N,5-trimethyl-4-oxo-3-phenyl-3,5-dihydro-4H-pyridozine[4,5-b] indole-1-acetamide) were analysed on the progression and severity of rheumatoid arthritis in vivo in the Mrl/lpr mice model, following chronic treatment (at 3 mg/kg, i.p. "
06/01/2006 - "The irreversible PBR antagonist, SSR180575, was found to reduce damage correlated with ischemia. "
09/01/2003 - "In perfused rat hearts, SSR180575 administered in vitro (100 nM-1 microM) or by oral pretreatment (3-30 mg/kg) greatly reduced the contractile dysfunction associated with ischemia-reperfusion. "
09/01/2003 - "To characterize and link the mitochondrial, cellular, and cardiac consequences of ischemia-reperfusion, we examined the effects of SSR180575 in several in vitro and in vivo models of oxidative stress. "
|4.||Neurodegenerative Diseases (Neurodegenerative Disease)
09/01/2003 - "In conclusion, we have demonstrated that peripheral benzodiazepine receptor play a major role in the regulation of cardiac ischemia-reperfusion injury and that SSR180575, a novel peripheral benzodiazepine receptor ligand, is of potential interest in these indications."
09/01/2003 - "The aim of this work was to determine the role of peripheral benzodiazepine receptor in ischemia-reperfusion injury and to test the potential beneficial effect of a novel potent peripheral benzodiazepine receptor ligand, 7-chloro-N,N,5-trimethyl-4-oxo-3-phenyl-3,5-dihydro-4H-pyridazino[4,5-b]indole-1-acetamide (SSR180575). "
|2.||PK 11195 (PK11195)
|6.||tranilast (N 5')
|7.||GABA-A Receptors (GABA(A) Receptor)